Anteris Technologies Global Corp. (AVR)
Nasdaq · Orthopedic, Prosthetic & Surgical Appliances & Supplies · Manufacturing · CIK 2011514 · fiscal year ends in Dec
Closing price $6.41 on 29 Oct 2026; 52-week range $3.38 to $10.57.
Key figures
The last twelve months reported, with the latest price and balance sheet.
- Revenue, last twelve months
- $2.2M
- Revenue growth
- -9.6%
- Net income, last twelve months
- -$103.6M
- Gross margin
- 75.0%
- Operating margin
- -4738.4%
- Net margin
- -4619.3%
- Free cash flow
- -$88.2M
- Return on equity
- -41.2%
- Market value
- $624.4M
- Cash
- $249.9M
- Debt
- $47.0K
- Debt to equity
- 0.00
- Shares outstanding
- 97.4M
Financial statements
Revenue, profit and cash flow by fiscal year, each year linked to its annual report.
| Fiscal year | Year end | Revenue | Operating income | Net income | EPS | Free cash flow | Filing |
|---|---|---|---|---|---|---|---|
| FY2025 | 31 Dec 2025 | $1.9M | -$93.9M | -$94.1M | -$2.55 | -$79.8M | 10-K filed 26 Feb 2026 |
| FY2024 | 31 Dec 2024 | $2.7M | -$78.4M | -$76.3M | -$3.68 | -$63.5M | 10-K filed 26 Feb 2026 |
By quarter
| Quarter | Quarter end | Revenue | Net income | EPS |
|---|---|---|---|---|
| Q2 FY2026 | 30 Jun 2026 | $1.0M | -$29.1M | -$0.30 |
| Q1 FY2026 | 31 Mar 2026 | $494.0K | -$23.0M | -$0.28 |
| Q4 FY2025 | 31 Dec 2025 | $310.0K | -$29.2M | -$0.74 |
| Q3 FY2025 | 30 Sep 2025 | $429.0K | -$22.2M | -$0.62 |
| Q2 FY2025 | 30 Jun 2025 | $618.0K | -$20.8M | -$0.58 |
| Q1 FY2025 | 31 Mar 2025 | $556.0K | -$21.9M | -$0.61 |
| Q4 FY2024 | 31 Dec 2024 | $536.0K | -$19.4M | -$0.72 |
| Q3 FY2024 | 30 Sep 2024 | $769.0K | -$21.9M | -$1.07 |
Revenue by segment
As the company reports it in the segment note of its annual report.
By region, FY2025
| Segment | Revenue | Share |
|---|---|---|
| United States | $1.6M | 84.1% |
| Germany | $272.0K | 14.2% |
| Australia | $33.0K | 1.7% |
Company events
The newest 8-K filings of 42 held.
| Filed | Form | Event | Items |
|---|---|---|---|
| 23 Sep 2026 | 8-K | Material agreement | 1.01, 9.01 |
| 17 Sep 2026 | 8-K | Leadership change | 5.02 |
| 8 Sep 2026 | 8-K | Leadership change | 5.02, 9.01 |
| 12 Aug 2026 | 8-K | Results | 2.02, 9.01 |
| 3 Aug 2026 | 8-K | Investor update | 7.01, 9.01 |
| 31 Jul 2026 | 8-K | Investor update | 7.01, 9.01 |
| 22 May 2026 | 8-K | Material agreement | 1.01, 9.01 |
| 13 May 2026 | 8-K | Leadership change | 5.02 |
| 13 May 2026 | 8-K | Results | 2.02, 9.01 |
| 29 Apr 2026 | 8-K | Agreement ended | 1.02 |
| 23 Apr 2026 | 8-K | Material agreement | 1.01 |
| 3 Mar 2026 | 8-K | Leadership change | 5.02, 9.01 |
Every filing
The newest filings with the SEC of 94 held.
| Filed | Form | Period |
|---|---|---|
| 28 Oct 2026 | PRE 14A | 2 Dec 2026 |
| 23 Sep 2026 | 8-K | 23 Sep 2026 |
| 17 Sep 2026 | 8-K | 12 Sep 2026 |
| 8 Sep 2026 | 8-K | 4 Sep 2026 |
| 12 Aug 2026 | 8-K | 11 Aug 2026 |
| 11 Aug 2026 | 10-Q | 30 Jun 2026 |
| 3 Aug 2026 | 8-K | 3 Aug 2026 |
| 31 Jul 2026 | 8-K | 31 Jul 2026 |
| 1 Jul 2026 | S-3ASR | – |
| 22 May 2026 | 8-K | 22 May 2026 |
| 13 May 2026 | 8-K | 12 May 2026 |
| 13 May 2026 | 8-K | 12 May 2026 |
Insider trades
Form 4 trades by officers, directors and 10% owners, last 12 months.
| Traded | Insider | Type | Shares | Price | Value | Held after | Form 4 |
|---|---|---|---|---|---|---|---|
| 6 Oct 2026 | L1 Capital Pty Ltd, 10% owner | Purchase | 272,695 | $7.18 | $2.0M | 6,358,271 | 8 Oct 2026 |
| 5 Oct 2026 | L1 Capital Pty Ltd, 10% owner | Purchase | 648,455 | $7.51 | $4.9M | 12,778,380 | 6 Oct 2026 |
| 2 Oct 2026 | L1 Capital Pty Ltd, 10% owner | Purchase | 236,354 | $7.78 | $1.8M | 12,129,925 | 6 Oct 2026 |
| 1 Oct 2026 | L1 Capital Pty Ltd, 10% owner | Purchase | 322,940 | $7.60 | $2.5M | 5,200,767 | 1 Oct 2026 |
| 30 Sep 2026 | L1 Capital Pty Ltd, 10% owner | Purchase | 74,286 | $7.72 | $573.5K | 4,877,827 | 1 Oct 2026 |
| 28 Aug 2026 | L1 Capital Pty Ltd, 10% owner | Sale outside a trading plan | 7,800 | $8.83 | $68.9K | 4,803,541 | 1 Sep 2026 |
| 11 Aug 2026 | L1 Capital Pty Ltd, 10% owner | Sale outside a trading plan | 375,815 | $9.30 | $3.5M | 4,811,341 | 12 Aug 2026 |
| 10 Aug 2026 | L1 Capital Pty Ltd, 10% owner | Sale outside a trading plan | 251,844 | $9.10 | $2.3M | 5,187,156 | 12 Aug 2026 |
| 6 Aug 2026 | L1 Capital Pty Ltd, 10% owner | Sale outside a trading plan | 174,721 | $8.10 | $1.4M | 5,439,000 | 10 Aug 2026 |
| 5 Aug 2026 | L1 Capital Pty Ltd, 10% owner | Sale outside a trading plan | 14,581 | $8.23 | $120.0K | 5,613,721 | 6 Aug 2026 |
| 4 Aug 2026 | L1 Capital Pty Ltd, 10% owner | Sale outside a trading plan | 480,608 | $8.30 | $4.0M | 5,628,302 | 6 Aug 2026 |
| 3 Aug 2026 | L1 Capital Pty Ltd, 10% owner | Sale outside a trading plan | 475,693 | $8.10 | $3.9M | 6,108,910 | 4 Aug 2026 |
Large holders
Schedule 13D and 13G filings by holders of more than 5% of the voting shares.
| Filed | Holder | Schedule | Stake | Shares |
|---|---|---|---|---|
| 3 Sep 2026 | L1 Capital Pty Ltd | 13G amended | 11.64% | 11.5M |
| 14 Aug 2026 | Nantahala Capital Management, LLC | 13G amended | 4.08% | 4.0M |
| 7 Aug 2026 | L1 Capital Pty Ltd | 13G amended | 13.46% | 13.3M |
| 6 Aug 2026 | FMR LLC | 13G | 7.5% | 7.3M |
| 15 May 2026 | Nantahala Capital Management, LLC | 13G amended | 6.28% | 6.1M |
| 4 May 2026 | Sio Capital Management, LLC | 13G amended | 5.54% | 5.4M |
| 27 Apr 2026 | BlackRock, Inc. | 13G | 5.01% | 4.9M |
| 13 Feb 2026 | Nantahala Capital Management, LLC | 13G amended | 7.52% | 3.1M |
| 5 Feb 2026 | L1 Capital Pty Ltd | 13G amended | 13.6% | 13.2M |
| 29 Jan 2026 | Medtronic plc | 13D | 16.2% | 15.7M |
Short interest
Shares sold short and not yet bought back, on each FINRA settlement date.
| Settlement | Shares short | Change | Days to cover |
|---|---|---|---|
| 15 Oct 2026 | 7.9M | +18.94% | 4.96 |
| 30 Sep 2026 | 6.7M | +3.9% | 7.65 |
| 15 Sep 2026 | 6.4M | -7.94% | 11.3 |
| 31 Aug 2026 | 7.0M | +0.6% | 9.93 |
| 14 Aug 2026 | 6.9M | -2.94% | 7.89 |
| 31 Jul 2026 | 7.1M | -11.53% | 6.93 |
| 15 Jul 2026 | 8.1M | +31.24% | 6.36 |
| 30 Jun 2026 | 6.2M | +8.35% | 3.62 |
Funds that hold it
From each fund's latest Form 13F.
152 funds held it at 30 Jun 2026: 81 added and 34 trimmed in the quarter. The largest:
| Fund | Shares | Value | Change in the quarter |
|---|---|---|---|
| L1 Capital Pty Ltd | 7,789,000 | $76.7M | 0 |
| FMR LLC | 6,868,086 | $67.7M | +3,966,736 |
| Nantahala Capital Management, LLC | 6,766,670 | $66.7M | – |
| BlackRock, Inc. | 5,771,213 | $56.8M | +882,060 |
| Sio Capital Management, LLC | 5,545,984 | $54.6M | +163,019 |
| Perceptive Advisors LLC | 3,425,476 | $33.7M | 0 |
| ADAR1 Capital Management, LLC | 3,145,096 | $31.0M | -644,036 |
| BVF Inc. | 3,000,000 | $29.6M | 0 |
| Ra Capital Management, L.P. | 3,000,000 | $29.6M | 0 |
| Ensign Peak Advisors, Inc | 2,390,200 | $23.5M | +303,089 |
Peers
Companies in the same industry.
- Intuitive Surgical Inc. (ISRG): revenue $11.6B, market value $155.5B
- Edwards Lifesciences Corp. (EW): revenue $6.5B, market value $54.5B
- Steris plc (STE): revenue $6.0B, market value $22.6B
- Zimmer Biomet Holdings, Inc. (ZBH): revenue $8.5B, market value $18.6B
- Smith & Nephew plc (SNN): revenue $6.2B, market value $13.3B
- Align Technology Inc. (ALGN): revenue $4.1B, market value $11.0B
- MSA Safety Inc. (MSA): revenue $1.9B, market value $6.9B
- Establishment Labs Holdings Inc. (ESTA): revenue $245.8M, market value $2.0B
- Cadre Holdings, Inc. (CDRE): revenue $685.6M, market value $1.3B
- Enovis Corp. (ENOV): revenue $2.3B, market value $1.3B